Neuro and Cardiovascular Pharmacology

Neuropharmacology is all about the effect of drugs towards the neurons and the mechanism and behavioural change. Cardiovascular pharmacology mainly focuses on heart disease and acute & chronic heart failure and for cardiac arrhythmia. The regenerative medicine therapies for cardiovascular treatment and novel biomarker strategies for cardiovascular disease are known to implement targeted drug therapy using the gene sequence alteration i.e. by using gene therapy concepts.

  • Angina
  • Heart failure
  • Pathological mechanism of neurological disorder
  • Antiarrhythmic drugs
  • Cardiovascular drugs and therapeutics
  • Hypertrophic cardiomyopathy
  • Nanotechnology advancement in Neuro therapy
  • Brain imaging technology & clinical neuroscience
  • Regenerative medicine therapies for cardiovascular treatment
  • Novel biomarker strategies for cardiovascular disease

Related Conference of Neuro and Cardiovascular Pharmacology

March 23-24, 2026

36th Annual European Pharma Congress

London, UK
March 24-25, 2026

11th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
April 16-17, 2026

19th European Biosimilars Congress

Rome, Italy
April 27-28, 2026

9th European Biopharma Congress

Paris, Aland Islands
May 28-29, 2026

3rd International Conference on Pharmacognosy

Madrid, Spain
June 08-09, 2026

20th World Drug Delivery Summit

London, UK
July 27-28, 2026

19th World Drug Delivery Summit

Paris, France
July 27-28, 2026

39th World Congress on Pharmacology

Rome, Italy
September 24-25, 2026

6th World Congress on Rare Diseases & Orphan Drugs

Paris, France
November 26-27, 2026

5th World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 26-27, 2026

5th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland

Neuro and Cardiovascular Pharmacology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in